These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10891021)

  • 1. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease.
    Han RK; Silverman ED; Newman A; McCrindle BW
    Arch Pediatr Adolesc Med; 2000 Jul; 154(7):694-9. PubMed ID: 10891021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
    Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
    Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW; Sleeper LA; McCrindle BW; Minich LL; Gersony W; Vetter VL; Atz AM; Li JS; Takahashi M; Baker AL; Colan SD; Mitchell PD; Klein GL; Sundel RP;
    N Engl J Med; 2007 Feb; 356(7):663-75. PubMed ID: 17301297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW; Takahashi M; Beiser AS; Burns JC; Bastian J; Chung KJ; Colan SD; Duffy CE; Fulton DR; Glode MP
    N Engl J Med; 1991 Jun; 324(23):1633-9. PubMed ID: 1709446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z; Kawasaki T
    Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki shock syndrome complicating a recurrence of Kawasaki disease.
    Tissandier C; Lang M; Lusson JR; Bœuf B; Merlin E; Dauphin C
    Pediatrics; 2014 Dec; 134(6):e1695-9. PubMed ID: 25384485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
    Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience.
    Guleria S; Pilania RK; Jindal AK; Bhattarai D; Suri D; Singh S
    Int J Rheum Dis; 2019 Jul; 22(7):1183-1187. PubMed ID: 30829007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki syndrome.
    Newburger JW; Burns JC
    Cardiol Clin; 1989 May; 7(2):453-65. PubMed ID: 2659185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Kawasaki disease in the British Isles.
    Dhillon R; Newton L; Rudd PT; Hall SM
    Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT; Lin CY; Hsieh KS; Tsuei DH; Meng CC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):15-22. PubMed ID: 2484055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm.
    Nomura Y; Masuda K; Yoshinaga M; Sameshima K; Miyata K
    Pediatr Int; 2002 Aug; 44(4):353-7. PubMed ID: 12139556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.